Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank86
3Y CAGR+0.0%
5Y CAGR+12.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+0.0%/yr
vs +22.3%/yr prior
5Y CAGR
+12.9%/yr
Recent deceleration
Acceleration
-22.3pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$46.08M-12.8%
2024$52.82M-0.1%
2023$52.87M+14.8%
2022$46.07M+11.1%
2021$41.45M+65.0%
2020$25.12M+98.4%
2019$12.66M-38.5%
2018$20.58M+171.8%
2017$7.57M+41.3%
2016$5.36M-